Repare Therapeutics Inc. |
Director |
Common Shares |
25.1K |
$60.9K |
$2.43 |
Dec 29, 2022 |
Direct |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Common Stock |
2.73M |
|
|
Jul 25, 2023 |
By Versant Venture Capital V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Common Stock |
275K |
|
|
Jul 25, 2023 |
By Versant Vantage II, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Common Stock |
207K |
|
|
Jul 25, 2023 |
By Versant Venture Capital V (Canada) LP |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Common Stock |
90.9K |
|
|
Jul 25, 2023 |
By Versant Ophthalmic Affiliates Fund I, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Common Stock |
82K |
|
|
Jul 25, 2023 |
By Versant Affiliates Fund V, L.P. |
Graphite Bio, Inc. |
Director |
Stock Option (right to buy) |
20K |
|
|
Jul 19, 2023 |
Direct |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Stock Option (Right to Buy) |
12.8K |
|
|
Jun 3, 2024 |
Direct |
CHINOOK THERAPEUTICS, INC. |
Director |
Common Stock |
0 |
|
$39.03 |
Aug 11, 2023 |
Direct |
CHINOOK THERAPEUTICS, INC. |
Director |
Common Stock |
0 |
|
$39.03 |
Aug 11, 2023 |
Indirect |
CHINOOK THERAPEUTICS, INC. |
Director |
Stock Option (Right to Buy) |
0 |
|
$26.12 |
Aug 11, 2023 |
Direct |
Repare Therapeutics Inc. |
Director |
Common Shares |
0 |
|
$2.43 |
Dec 29, 2022 |
Indirect |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Affiliates Fund V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Ophthalmic Affiliates Fund I, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V (Canada) LP |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-1 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Affiliates Fund V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-1 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Ophthalmic Affiliates Fund I, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-1 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V (Canada) LP |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-1 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Affiliates Fund V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Ophthalmic Affiliates Fund I, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V (Canada) LP |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series B-2 Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series C Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Affiliates Fund V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series C Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Ophthalmic Affiliates Fund I, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series C Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V (Canada) LP |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series C Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Venture Capital V, L.P. |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
Series D Preferred Stock |
0 |
|
|
Jul 25, 2023 |
By Versant Vantage II, L.P. |